584 related articles for article (PubMed ID: 26061015)
1. Serum Vitamin D Levels and Polycystic Ovary syndrome: A Systematic Review and Meta-Analysis.
He C; Lin Z; Robb SW; Ezeamama AE
Nutrients; 2015 Jun; 7(6):4555-77. PubMed ID: 26061015
[TBL] [Abstract][Full Text] [Related]
2. Effects of vitamin D supplementation in women with polycystic ovary syndrome: a review.
Menichini D; Facchinetti F
Gynecol Endocrinol; 2020 Jan; 36(1):1-5. PubMed ID: 31187648
[TBL] [Abstract][Full Text] [Related]
3. Calcium plus vitamin D supplementation affects glucose metabolism and lipid concentrations in overweight and obese vitamin D deficient women with polycystic ovary syndrome.
Asemi Z; Foroozanfard F; Hashemi T; Bahmani F; Jamilian M; Esmaillzadeh A
Clin Nutr; 2015 Aug; 34(4):586-92. PubMed ID: 25300649
[TBL] [Abstract][Full Text] [Related]
4. A Randomized, Controlled Trial of Vitamin D Supplementation on Cardiovascular Risk Factors, Hormones, and Liver Markers in Women with Polycystic Ovary Syndrome.
Javed Z; Papageorgiou M; Deshmukh H; Kilpatrick ES; Mann V; Corless L; Abouda G; Rigby AS; Atkin SL; Sathyapalan T
Nutrients; 2019 Jan; 11(1):. PubMed ID: 30658483
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D supplementation has no effect on insulin resistance assessment in women with polycystic ovary syndrome and vitamin D deficiency.
Ardabili HR; Gargari BP; Farzadi L
Nutr Res; 2012 Mar; 32(3):195-201. PubMed ID: 22464806
[TBL] [Abstract][Full Text] [Related]
6. The effect of Vitamin D supplementation on hormonal and glycaemic profile of patients with PCOS: A meta-analysis of randomised trials.
Pergialiotis V; Karampetsou N; Panagopoulos P; Trakakis E; Papantoniou N
Int J Clin Pract; 2017 Jun; 71(6):. PubMed ID: 28524342
[TBL] [Abstract][Full Text] [Related]
7. Intrinsic factors rather than vitamin D deficiency are related to insulin resistance in lean women with polycystic ovary syndrome.
Sahin S; Eroglu M; Selcuk S; Turkgeldi L; Kozali S; Davutoglu S; Muhcu M
Eur Rev Med Pharmacol Sci; 2014 Oct; 18(19):2851-6. PubMed ID: 25339479
[TBL] [Abstract][Full Text] [Related]
8. The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
Maktabi M; Chamani M; Asemi Z
Horm Metab Res; 2017 Jul; 49(7):493-498. PubMed ID: 28679140
[TBL] [Abstract][Full Text] [Related]
9. The role of vitamin D in metabolic disturbances in polycystic ovary syndrome: a systematic review.
Krul-Poel YH; Snackey C; Louwers Y; Lips P; Lambalk CB; Laven JS; Simsek S
Eur J Endocrinol; 2013 Dec; 169(6):853-65. PubMed ID: 24044903
[TBL] [Abstract][Full Text] [Related]
10. Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome.
Wehr E; Pilz S; Schweighofer N; Giuliani A; Kopera D; Pieber TR; Obermayer-Pietsch B
Eur J Endocrinol; 2009 Oct; 161(4):575-82. PubMed ID: 19628650
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D-associated polymorphisms are related to insulin resistance and vitamin D deficiency in polycystic ovary syndrome.
Wehr E; Trummer O; Giuliani A; Gruber HJ; Pieber TR; Obermayer-Pietsch B
Eur J Endocrinol; 2011 May; 164(5):741-9. PubMed ID: 21389086
[TBL] [Abstract][Full Text] [Related]
12. Effect of vitamin D on biochemical parameters in polycystic ovary syndrome women: a meta-analysis.
Xue Y; Xu P; Xue K; Duan X; Cao J; Luan T; Li Q; Gu L
Arch Gynecol Obstet; 2017 Feb; 295(2):487-496. PubMed ID: 27933387
[TBL] [Abstract][Full Text] [Related]
13. Effects of nutrition on metabolic and endocrine outcomes in women with polycystic ovary syndrome: an umbrella review of meta-analyses of randomized controlled trials.
Moslehi N; Zeraattalab-Motlagh S; Rahimi Sakak F; Shab-Bidar S; Tehrani FR; Mirmiran P
Nutr Rev; 2023 Apr; 81(5):555-577. PubMed ID: 36099162
[TBL] [Abstract][Full Text] [Related]
14. Hormonal and Metabolic Effects of Coenzyme Q10 and/or Vitamin E in Patients With Polycystic Ovary Syndrome.
Izadi A; Ebrahimi S; Shirazi S; Taghizadeh S; Parizad M; Farzadi L; Gargari BP
J Clin Endocrinol Metab; 2019 Feb; 104(2):319-327. PubMed ID: 30202998
[TBL] [Abstract][Full Text] [Related]
15. Effects of vitamin D supplementation on metabolic parameters of women with polycystic ovary syndrome: a meta-analysis of randomized controlled trials.
Wang L; Wen X; Lv S; Tian S; Jiang Y; Yang X
Gynecol Endocrinol; 2021 May; 37(5):446-455. PubMed ID: 32909865
[TBL] [Abstract][Full Text] [Related]
16. Effect of vitamin D on clinical and biochemical parameters in polycystic ovary syndrome women: A meta-analysis.
Jia XZ; Wang YM; Zhang N; Guo LN; Zhen XL; Li H; Wei L
J Obstet Gynaecol Res; 2015 Nov; 41(11):1791-802. PubMed ID: 26370491
[TBL] [Abstract][Full Text] [Related]
17. Associations of vitamin D concentration with metabolic and hormonal indices in women with polycystic ovary syndrome presenting abdominal and gynoidal type of obesity.
Kozakowski J; Kapuścińska R; Zgliczyński W
Ginekol Pol; 2014 Oct; 85(10):765-70. PubMed ID: 25546928
[TBL] [Abstract][Full Text] [Related]
18. Effect of Two Different Doses of Vitamin D Supplementation on Metabolic Profiles of Insulin-Resistant Patients with Polycystic Ovary Syndrome.
Jamilian M; Foroozanfard F; Rahmani E; Talebi M; Bahmani F; Asemi Z
Nutrients; 2017 Nov; 9(12):. PubMed ID: 29186759
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D in polycystic ovary syndrome: Relationship to obesity and insulin resistance.
Joham AE; Teede HJ; Cassar S; Stepto NK; Strauss BJ; Harrison CL; Boyle J; de Courten B
Mol Nutr Food Res; 2016 Jan; 60(1):110-8. PubMed ID: 26255991
[TBL] [Abstract][Full Text] [Related]
20. The effect of vitamin D supplementation on insulin resistance, visceral fat and adiponectin in vitamin D deficient women with polycystic ovary syndrome: a randomized placebo-controlled trial.
Seyyed Abootorabi M; Ayremlou P; Behroozi-Lak T; Nourisaeidlou S
Gynecol Endocrinol; 2018 Jun; 34(6):489-494. PubMed ID: 29271278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
